Boston
Our Board of Advisors, all industry leaders, have made a powerful statement by supporting Life Science Cares and our goal to end poverty in our community. Annually, our Advisors make a personal financial contribution to cover LSC’s administrative costs, allowing us to channel money raised from our event fundraisers, Corporate Membership Program, and from individuals to our partner organizations.
Our Board of Advisor members also choose to volunteer with their companies and recruit their colleagues to join in this collective effort.

Rich Aldrich
General Partner
Longwood Fund

Stephane Bancel
CEO
Moderna Therapeutics

Mark Bamforth
Founder
Thairm Bio

Imran Babar
Chief Business & Financial Officer
Sudo Biosciences

Peter Barrett
Partner
Atlas Venture

Jeff Albers
Venture Partner
Atlas Venture

Mitch Bloom
Partner
Goodwin

Joshua Boger
Foundation & CEO (Former)
Vertex Pharmaceuticals

Bruce Booth
Partner
Atlas Venture

Katrine Bosley
Founding CEO
DaCapo Brainscience

Michael Broxson
Principal
Tennyson Advisory

Paul Burgess
Chief Operating Officer and Chief Business Officer
Kailera Therapeutics

Thomas Carey
Founder & Partner
Perspective Group

Bharatt Chowrira
CEO & Board Member
PureTech Health

Tim Clackson
President and CEO
IDRx

Ron Cooper
Global CEO | Board Chair & Director

Zoltan Csimma
Senior Biotech Executive

Elisabet De los Pinos
CEO
Aura Biosciences

Dee Dee DeMan
Chairman & CEO
Bench International

Tom DesRosier
Executive Vice President & Chief Legal Officer
Seres Therapeutics

Steven Dickman
Owner
CBT Advisors

Wendy Erler
VP, Head of STAR Patient Insights & Advocacy
Astra Zeneca, Alexion Rare Disease

Greg Erman
Member
Mass Medical Angels

Douglas Fambrough
Managing Partner
KCap Biotechnology Fund

James Foster
Chairman, President & CEO
Charles River Labs

Jean George
General Partner
Lightstone Ventures

Jeff Goater
Venture Partner
The Column Group

Brian Goff
Chief Commercial and Global Operations Officer
Alexion

Dave Grayzel
Partner
Atlas Venture

Penny Heaton
Global Therapeutic Head, Vaccines
Janssen

Michael Heffernan
Chairman
Collegium Pharmaceuticals

Jeffrey Hemman
Partner
PWC

Bruce Jacobs
Chief Financial Officer
Kymera Therapeutics

Ed Kaye, MD
CEO & Director
Stoke Therapeutics

Adam Koppel
Managing Director
Bain Capital Life Sciences

Nerissa Kreher
Founder
Mountainview Clinical Development Consulting

Michel Lagarde
Chief Operating Officer
Thermo Fisher

Donna Lavoie
CEO
LavoieHealthScience

Mark Levin
Partner
Third Rock Ventures

Ankit Mahadevia
Chairman
Spero Therapeutics

David Meeker
President & CEO
Rhythm Pharmaceuticals

Dave Mello
President
The Richmond Group

Jill Milne
CEO
Astria Therapeutics

Ted Myles
Chief Operating Officer & Chief Financial Officer
Scholar Rock

Susan Nemetz
Founder & CEO
The NemetzGroup

Leslie Orne
President & CEO
Trinity Life Sciences

Paula Ragan
CEO & President
X4 Pharmaceuticals

Jigar Raythatha
Partner
Third Rock Ventures

Laurence Reid
Director
Garuda Therapeutics

Jason Rhodes
Partner
Atlas Venture

Alicia Secor
President & CEO
Atalanta Therapeutics

Eric Shaff
President & CEO
Seres Therapeutics

Bill Sibold
CEO
Madrigal Pharmaceuticals

Nancy Simonian
Biotech Executive & Board Member

Otello Stampacchia
Founder
Omega Funds

Mary Thistle
Director

Rajeev Venkayya
CEO
Aerium Therapeutics

Shelia Violette
Co-Founder, Chief Scientific Officer & President of Research
Q32 Bio

Christoph Westphal
General Partner
Longwood Fund

Marc Beer
Executive Chairman
BioTE

Kevin Bitterman
Partner
Atlas Venture

Pablo Cagnoni
President and Head of R&D
Incyte

Abbie Celniker
Partner
Third Rock Ventures

Hugh Cole
Board Member
Astria Therapeutics

Neal Dunn
Partner
Trinity

Paul Enderle
Managing Director
Baycross Capital Group

Elan Ezickson
Biotech Board Member

Joe Farmer
President and Chief Operating Officer
Zenas BioPharma

Chris Gabrieli
Biotech VC (Retired)

Nick Galakatos
Global Head
Blackstone Life Sciences

Halley Gilbert
Chief Legal Officer Chief Legal Officer
CARGO Therapeutics

Glen Giovannetti
Global Biotechnology Leader (Retired)
EY

John Glasspool
Venture Partner
Agent Capital

Mike Gray
Chief Financial and Chief Operating Officer
Upstream Bio

Chris Guiffre
President & COO
Auron Therapeutics

Bill Heiden
Healthcare Executive & Board Member

Colin Hill
CEO, Chairman & Co-Founder
Aitia

Andrew Hirsch
CEO
C4 Therapeutics

Tim Hunt
CEO
Alliance for Regenerative Medicine

Doug Ingram
CEO
Sarepta

Pierre Jacquet
Managing Director & Partner
L.E.K. Consulting

Brian Johnson
President
MassMEDIC

Rosanna Kapeller
President & CEO
Rome Therapeutics

Jason Kelly
CEO
Ginkgo Bio

Richard Kertzman
Sr. Managing Director
Citizens

Iya Khalil
Vice President and Head of Data, A.I. & Genome Sciences
Merck

Bjorn Koch
Senior Vice President, Wealth Management
UBS

Joanne Kotz
President & CEO
Jnana Therapeutics

Peter Latham
CEO
Latham Biopharma Group

Mike Bonney
Biotech Executive & Board Member

Jeff Leerink
CEO
SVB Leerink

Jeff Leiden
Executive Chairman
Vertex Pharmaceuticals

Daniel Lynch
Chairman
bluebird bio

Ivana Magovcevic-Liebisch
President & CEO
Vigil Neuroscience

Eddie Martucci
Chair of the Board
Akili Interactive

Katie McCarthy
Managing Director
Halloran Consulting Group

Geoffrey McDonough
President & CEO
Generation Bio

Bill McVicar
Principal Consultant
BioStrat Consulting

Cherie Myatt
President
OPEN Health Patient Engagement

Marian Nakada
Vice President, Venture Investments
J&J

Amir Nashat
Partner
Polaris Partners

Mike O'Hara
Partner
Deloitte

Douglas Pagan
Chief Financial Officer & Chief Operating Office
Jnana Therapeutics

Paris Panayiotopoulos
Partner and member of the Investment Committee
The Blackstone Group

Deval Patrick
Founder & Chairman
TogetherFUND

Rene Russo
CEO
Xilio Therapeutics

Nabiha Saklayen
Co-Founder & CEO
Cellino Biotech

Ian Sanderson
Chief Financial Officer
Nimbus Pharmaceuticals

Mike Tomsicek
Biotech Board Member

Samantha Truex
Biotech Board Member

Joseph Vittiglio
Chief Legal & Business Officer
bluebird bio

Joe vonRickenbach
Biotech Board Member

Leslie Williams
Co-Founder, President & CEO
hC Bioscience

Cissy Young
Partner
Catalyst Advisors

Hilary Malone
CEO
NewCo

Michael Gilman
CEO
Arrakis Therapeutics

Tracey Sacco
Chief Commercial Officer
Scholar Rock

Skip Kelly
Managing Director
JP Morgan

Kate Walsh
Managing Director, Life Science & Healthcare
HSBC Innovation Banking

Arjun Goyal
Co-Founder and Managing Director
Vida Ventures

Stefan Vitorovic
Co-Founder and Managing Director
Vida Ventures

Jo Viney
CEO
Seismic Therapeutics

Steven Tregay
Managing Partner
Mission Bio Capital

Marnie Hoolahan
President
The Nemetz Group

Doug Kerr
Venture Partner
Atlas Venture

Melissa Manno
Chief Human Resources Officer
Viridian Therapeutics

Joshua Philbrook
President
DENS Facility Services

Alice Pomponio
Managing Director
BrightEdge at American Cancer Society

Art Krieg
Founder, President, and acting CEO/CSO
Zola Therapeutics

Kara Coluccio
Consultant, Biopharma and Board Practices
Spencer Stuart

Ram Aiyar
CEO
Korro Bio

Matt Henn
EVP, Chief Scientific Officer
Seres Therapeutics

Samantha Singer
President & CEO
Abata Therapeutics

Ramani Varanasi
Managing Director
Revive Advisors

Alex Harding
Entrepreneur in Residence
Atlas Venture

Michael Gladstone
Partner
Atlas Venture

Dr. Phil Sharp

Nova Diop
SVP & Co-Chair Diversity, Equity & Inclusion Executive Recruitment
Bench International

Andy Beck
CEO
PathAI

Dipal Doshi
President & CEO
Entrada Therapeutics

Paul Biondi
President
Pioneering Medicines

Mike Cloonan
President & CEO
Sionna Therapeutics

Jill Zunshine
Senior Vice President and Head of Global Real Estate, Facilities, and Procurement
Takeda

Courtney Thorne
Partner - Public Companies and Capital Markets
Cooley

Simon Read
CEO
Mariana Oncology

Donna Higgins
Founder & CEO
The Higgins Group, Inc.

James Ehret
Managing Director, Life Sciences
Banc of California

Parag Shah
Founding Managing Director & CEO
K2 HealthVentures

Andrew Miller
Founder & COO
Karuna Therapeutics

Christopher Viehbacher
President & CEO
Biogen

Dan Rosan
CBO & CFO
Ascidian Therapeutics

Brian Tobin
CEO
Tobin Scientific

Mark Mallon
CEO and Board Director
George Medicines

Tamar Thompson
Head, Global Corporate Affairs
Alexion Pharmaceuticals

Christine Brennan
Managing Director
Vertex Ventures

Reshma Kewalramani
CEO
Vertex Pharmaceuticals

Ellen Travers
Partner
Chartwell Partners

Christy Kahana
Founder & CEO
Claria Partners

Amy Atwood
VP, U.S. Business Unit and U.S. Region Communications & Philanthropy
Takeda

Nick Amarante
Executive Vice President & Boston Market Leader
Hughes Marino

Jessica Ballinger
President & CEO
Lyndra Therapeutics

Warren Browne
Founder & CEO
Browne Consulting Group

Bill Collins
Partner, Life Science Practice
Goodwin

Maia Harris
Troutman Pepper Hamilton Sanders LLP

Darrin Miles
CEO
Nested Therapeutics

Holly Reeves
Partner
PwC

Craig Hilts
Partner
WilmerHale

Stefan Spazek
Executive Vice President
Capital Advisors

Shirley Kuhlmann
EVP, General Counsel & Chief Administrative Officer
Collegium Pharmaceutical

Katherine Andersen
Head of Life Science & Healthcare
HSBC

Nathan Dowden
President & COO
Entrada Therapeutics

Joseph Goldberg
Partner, Strategy & Management Consulting
RSM US LLP

Keira Driansky
Executive Vice President, President of North America
Ipsen

Lyn Baranowski
Chief Executive Officer
Avalyn Pharma Inc.

Caren Deardorf
Chief Commercial & Strategy Officer
Editas Medicine

Irina Margine, Ph.D.
Biotech Sector Lead, Private Equity
Wellington Management

Brendan St. Amant
General Counsel & Corporate Secretary
Seismic Therapeutic

Mitch Perez
Vice President, Life Sciences
Cresa

Steven Favaloro
Chairman & CEO
Genezen

Liang Schweizer
Founder, Chairperson, and CEO
HiFiBiO

Michelle DesChenes
Partner, CHRO Practice
Caldwell

Rajiv Patni
CEO
Judo Bio

Sean Ring
SVP, Corporate Development and Program Leadership
Xilio Therapeutics

Tom Aicardi
Executive Vice President
Triumvirate Environmental